The FDA has cleared Abbott’s iPhone FreeStyle Libre 2 iOS app for use with the built-in continuous glucose monitoring system, which provides up-to-the-minute glucose readings and optional alarms.
However, the agency declined Ardelyx’s investigational treatment to control serum phosphate in adult patients with chronic kidney disease on dialysis, stating that the treatment effect was “small and of unclear clinical significance”.
Patients with type 2 diabetes and obesity were quite satisfied after bariatric surgery – they reported improved physical function, general health perception, energy / fatigue and diabetes-related quality of life – compared to patients who only received intensive care therapy, according to New Findings from the STAMPEDE study. (Annals of Surgery)
In people with chronic kidney disease, metabolic syndrome was not only common, but also increased the risk of all-cause mortality and cardiovascular events by 26% and 48%, respectively. (Journal of Internal Medicine)
With the COVID-19 pandemic causing many to shed a few pounds, Novo Nordisk CEO said sales of its new obesity drug Wegovy (injectable 2.4 mg semaglutide) are growing sharply. (Reuters)
Exercising and reducing daily intake of just 250 calories has helped older adults with obesity improve aortic stiffness.
In related news, daily treatment with 3.0 mg of liraglutide (Saxenda) in conjunction with lifestyle intervention helped reduce visceral adipose tissue in adults who were overweight or obese. (The Lancet Diabetes & Endocrinology)
During the first wave of the COVID-19 pandemic – which lasted roughly from late March to late June 2020 – children who developed newly onset type 1 diabetes presented with more severe cases, characterized by more cases of diabetic ketoacidosis were. (Diabetic medicine)
